DK1713461T3 - Forbindelser med antitumor-virkning - Google Patents

Forbindelser med antitumor-virkning

Info

Publication number
DK1713461T3
DK1713461T3 DK05707260.5T DK05707260T DK1713461T3 DK 1713461 T3 DK1713461 T3 DK 1713461T3 DK 05707260 T DK05707260 T DK 05707260T DK 1713461 T3 DK1713461 T3 DK 1713461T3
Authority
DK
Denmark
Prior art keywords
compounds
antitumor effect
antitumor
effect
Prior art date
Application number
DK05707260.5T
Other languages
English (en)
Inventor
Gianfranco Peluso
Menotti Calvani
Original Assignee
Defiante Farmaceutica Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Defiante Farmaceutica Sa filed Critical Defiante Farmaceutica Sa
Application granted granted Critical
Publication of DK1713461T3 publication Critical patent/DK1713461T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK05707260.5T 2004-02-12 2005-02-08 Forbindelser med antitumor-virkning DK1713461T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000230A ITMI20040230A1 (it) 2004-02-12 2004-02-12 Composti ad attivita' antitumorale
PCT/EP2005/001257 WO2005077354A1 (en) 2004-02-12 2005-02-08 Compounds having antitumor activity

Publications (1)

Publication Number Publication Date
DK1713461T3 true DK1713461T3 (da) 2010-11-22

Family

ID=34856910

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05707260.5T DK1713461T3 (da) 2004-02-12 2005-02-08 Forbindelser med antitumor-virkning

Country Status (20)

Country Link
US (1) US7652066B2 (da)
EP (1) EP1713461B1 (da)
JP (1) JP2007522165A (da)
KR (1) KR101220331B1 (da)
CN (1) CN1917867B (da)
AR (1) AR047742A1 (da)
AT (1) ATE476973T1 (da)
AU (1) AU2005211906B2 (da)
BR (1) BRPI0507664A (da)
CA (1) CA2556069C (da)
CY (1) CY1111048T1 (da)
DE (1) DE602005022828D1 (da)
DK (1) DK1713461T3 (da)
ES (1) ES2350695T3 (da)
HK (1) HK1099687A1 (da)
IT (1) ITMI20040230A1 (da)
PL (1) PL1713461T3 (da)
SI (1) SI1713461T1 (da)
TW (1) TWI361802B (da)
WO (1) WO2005077354A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8314144B2 (en) * 2004-02-12 2012-11-20 Defiante Farmaceutica, S.A. Compounds having antitumor activity
CA2680366C (en) 2007-03-09 2016-06-21 University Health Network Inhibitors of carnitine palmitoyltransferase and treating cancer
US8680282B2 (en) 2007-08-01 2014-03-25 University Health Network Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer
AU2009242240B2 (en) * 2008-04-29 2011-09-22 F. Hoffmann-La Roche Ag 4-dimethylaminobutyric acid derivatives
KR20110044209A (ko) * 2008-06-24 2011-04-28 다라 바이오싸이언시즈, 아이엔씨. 효소 억제제 및 그의 용도
JP5746988B2 (ja) * 2012-02-15 2015-07-08 ライオン株式会社 カプセル皮膜及びカプセル

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1299266B1 (it) 1998-05-15 2000-02-29 Sigma Tau Ind Farmaceuti Inibitori reversibili della carnitina palmitoil trasferasi
ATE330598T1 (de) * 1999-11-12 2006-07-15 Univ Johns Hopkins Behandlung von krebs durch erhöhung des malonyl- coa-spiegels

Also Published As

Publication number Publication date
EP1713461B1 (en) 2010-08-11
PL1713461T3 (pl) 2011-01-31
CA2556069A1 (en) 2005-08-25
AR047742A1 (es) 2006-02-15
TWI361802B (en) 2012-04-11
KR20060134059A (ko) 2006-12-27
SI1713461T1 (sl) 2010-12-31
ATE476973T1 (de) 2010-08-15
HK1099687A1 (en) 2007-08-24
KR101220331B1 (ko) 2013-01-09
EP1713461A1 (en) 2006-10-25
US20080227683A1 (en) 2008-09-18
TW200530154A (en) 2005-09-16
AU2005211906A1 (en) 2005-08-25
JP2007522165A (ja) 2007-08-09
DE602005022828D1 (de) 2010-09-23
CN1917867A (zh) 2007-02-21
WO2005077354A1 (en) 2005-08-25
US7652066B2 (en) 2010-01-26
CY1111048T1 (el) 2015-06-11
ITMI20040230A1 (it) 2004-05-12
ES2350695T3 (es) 2011-01-26
BRPI0507664A (pt) 2007-07-17
CA2556069C (en) 2013-04-23
CN1917867B (zh) 2011-03-16
AU2005211906B2 (en) 2009-07-30

Similar Documents

Publication Publication Date Title
CY2019034I1 (el) 4-φαινυλαμινο-κιναζολιν-6-υλ-αμιδια
NO20161521L (no) Antivirale forbindelser
IS8578A (is) 3- karbamoýl - 2- pýridón afleiður
DK1778702T3 (da) Antivirale forbindelser
DE602005020968D1 (de) n dafür
DK1809978T3 (da) Modul-skydebane
DK1725553T3 (da) Tetrahydropyridoindolderivater
DK1761541T3 (da) Pyrrazolo-pyrimidin-derivater
ATE540935T1 (de) Chinazolinderivate
ATE417830T1 (de) Sulfonylbenzimidazolderivate
ATE392425T1 (de) Thiazolyl-dihydro-indazole
ATE520680T1 (de) Hiv-hemmende 5-heterocyclylpyrimidine
ATE442044T1 (de) Herbizid-safener-kombination
ATE459633T1 (de) Makrolide
ATE430142T1 (de) Phenylpiperazin-methanon-derivate
DK1839662T3 (da) Antitumormiddel
ATE522514T1 (de) Dihydropyran-2-onverbindungen mit antitumorwirkung
ATE404542T1 (de) 4-phenylpyrimidin-2-carbonitrilderivate
DE502005000496D1 (de) Verstellvorrichtung
ATE365731T1 (de) 4-amino-5-cyanopyrimidinderivate
DK1713461T3 (da) Forbindelser med antitumor-virkning
AT500198B1 (de) Ladewagen
ATE389633T1 (de) Omega-phenyloctanamide
SE0400476L (sv) Komponent
AT500249A3 (de) Scheibenegge